EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features. 2024

Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
Universidade Federal de Minas Gerais - UFMG, School of Dentistry, Department of Oral Surgery and Pathology, Belo Horizonte, MG, Brazil.

The aim of this study was to evaluate the expression of the EZH2 protein and describe the clinical and microscopic characteristics of adenoid cystic carcinoma (ACC) and pleomorphic adenoma (PA). The study included 16 ACC cases and 12 PA. All ACC and PA cases were positive for EZH2 and the ACC samples showed significantly higher EZH2 expression. The clinical and microscopic covariates were described in relation to EZH2 staining in ACC samples. The highest mean values of EZH2 were observed in cases with local metastasis, recurrence, perineural invasion, and predominantly cribriform growth pattern without solid areas. EZH2 is a potential marker of malignancy.

UI MeSH Term Description Entries
D008949 Adenoma, Pleomorphic A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed) Mixed Salivary Gland Tumor,Salivary Gland Tumor, Mixed,Syringoma, Chondroid,Adenomas, Pleomorphic,Chondroid Syringoma,Chondroid Syringomas,Pleomorphic Adenoma,Pleomorphic Adenomas,Syringomas, Chondroid
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003528 Carcinoma, Adenoid Cystic Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed) Cylindroma,Adenocystic Carcinoma,Adenocystic Carcinomas,Adenoid Cystic Carcinoma,Adenoid Cystic Carcinomas,Carcinoma, Adenocystic,Carcinomas, Adenocystic,Carcinomas, Adenoid Cystic,Cylindromas,Cystic Carcinoma, Adenoid,Cystic Carcinomas, Adenoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071221 Enhancer of Zeste Homolog 2 Protein A histone-lysine N-methyltransferase and catalytic subunit of Polycomb Repressive Complex 2. It methylates LYSINE 9 (H3K9me) and LYSINE 27 (H3K27me) of HISTONE H3, leading to transcriptional repression of the affected target gene. EZH2 also methylates non-histone proteins such as GATA4 TRANSCRIPTION FACTOR and the nuclear receptor RORA. It regulates CIRCADIAN CLOCKS via histone methylation of circadian protein gene PROMOTER REGIONS, and its repressive activity is also important for the identity and differentiation of EMBRYONIC STEM CELLS. Enhancer of Zeste Homolog 2,Histone-Lysine N-Methyltransferase EZH2,Lysine N-Methyltransferase-6,EZH2, Histone-Lysine N-Methyltransferase,Histone Lysine N Methyltransferase EZH2,Lysine N Methyltransferase 6
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
May 2013, Applied immunohistochemistry & molecular morphology : AIMM,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
June 1985, Histopathology,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
June 2009, Head and neck pathology,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
January 2018, Journal of cancer research and therapeutics,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
January 2017, Archives of oral biology,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
December 1990, Archives of pathology & laboratory medicine,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
January 2011, Journal of cancer research and therapeutics,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
July 2017, Pathology oncology research : POR,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
January 2016, Turk patoloji dergisi,
Mariana Saturnino de Noronha, and Karolina Skarlet Silva Viana, and Maria Cássia Ferreira de Aguiar, and Cristiane Helena Squarize, and Mauro Henrique Nogueira Guimarães de Abreu, and Elismauro Francisco Mendonça, and Vanessa de Fátima Bernardes
January 1987, The International journal of biological markers,
Copied contents to your clipboard!